It Was Never About Willpower

Let me start with something that took medicine far too long to say out loud.

Obesity is a chronic disease. Not a lifestyle choice. Not a failure of discipline. Not a reflection of how much you care about yourself or your health. A chronic, complex, biologically-driven disease — with its own hormonal mechanisms, its own genetic contributors, its own feedback systems, and its own clinical guidelines for treatment.

The American Medical Association formally recognized this in 2013. But the culture of medicine — and the wider culture — has been slow to follow. Patients are still walking out of appointments having been told to try harder. Still being handed a printed pamphlet about portion sizes by someone who spent four minutes with them. Still having legitimate symptoms dismissed because the chart says their BMI is high and the assumption is that the number explains everything.

It doesn’t.

I’ve sat with patients who have spent decades doing everything they were told, eating less, moving more, tracking every meal…and still felt like their body was working against them. Not because they were doing it wrong. Because nobody had explained to them that the biology was doing exactly what it was designed to do, and that willpower was never the tool for the job.

That’s what this piece is about. Not to excuse anything, and not to say that what you eat and how you move don’t matter, they absolutely do and we’ll get there. But to give you a framework that replaces shame with understanding. Because shame has never healed a chronic disease. Understanding actually can.

Part 1: Recognizing the Pattern

The Biology Your Doctor Didn’t Have Time to Explain

Here’s what happens in the body when significant weight is gained and then lost.

Body fat — adipose tissue — is not passive storage. It is an active endocrine organ that produces hormones, releases inflammatory signals, and communicates constantly with your brain, your pancreas, your liver, and your cardiovascular system. When fat tissue becomes dysfunctional, which happens with excess accumulation, that communication system goes wrong in ways that make weight maintenance genuinely difficult, independent of behavior or intention.

The most important hormone in this story is leptin.

Leptin is produced by fat cells and tells your brain when you have enough energy — it’s the satiety signal, the metabolic regulator. In people with obesity, leptin levels are chronically high. That sounds like it should help. The problem is that the brain stops hearing the signal, it becomes leptin resistant. The hormone is there. The receptor stops responding. And the brain interprets the situation as starvation, even when it isn’t. So it responds the way it’s designed to respond to starvation: it raises appetite, lowers metabolic rate, and prioritizes fat storage.

This is why people who lose weight often experience intense hunger, a slower metabolism, and a powerful biological pull back toward where they started. These are not signs of weakness. They are documented physiological adaptations and they persist for years after weight loss, sometimes longer [1].

There’s a second mechanism worth knowing: the body appears to defend a particular weight range with remarkable determination. When weight drops below that range, multiple systems activate simultaneously to restore it metabolism slows, hunger hormones rise, satiety hormones fall, energy expenditure drops. And the more diet cycles someone has been through, the more times this has happened, the more entrenched the defense becomes.

This is the biology behind what people call yo-yo dieting. It isn’t a character flaw pattern. It’s a physiological one. And understanding it changes how we approach treatment entirely.

What’s Actually Driving the Weight

When a patient comes to me struggling with weight that hasn’t responded to genuine effort, my first job is to ask: what is driving this? Because body weight is not a simple equation. It is a result, and the result can be shaped by many different upstream causes.

Here’s what I look for:

Insulin resistance — chronically elevated insulin signals the body to store fat and makes it harder to access stored fat for energy. If you’ve ever noticed that your hunger surges in the afternoon, that you feel worse after eating certain things, or that your weight tends to accumulate in your midsection specifically, insulin resistance may be part of your picture. We covered this in depth earlier in this series.

Thyroid dysfunction — hypothyroidism slows metabolic rate, increases fluid retention, and changes how the body handles fat. It is one of the most commonly missed contributors to weight that won’t shift, particularly in women. We’ll cover this in the next masterclass. If this resonates for you, don’t wait.

Hormonal shifts — the perimenopause transition in women and declining testosterone in men both change how the body distributes and stores fat. Elevated cortisol from chronic stress does the same thing, specifically driving fat toward the abdomen. These aren’t side effects of getting older — they are hormonal mechanisms that deserve clinical attention.

Sleep disruption — if you’ve ever woken up ravenous after a bad night of sleep and wondered why: this is why. Poor sleep raises ghrelin (the hunger hormone), lowers leptin (the satiety hormone), elevates cortisol, and impairs glucose metabolism. Someone sleeping five hours a night is navigating a hormonally distinct metabolic environment from someone sleeping eight. That difference is real and measurable.

Medication effects — certain antidepressants, antipsychotics, corticosteroids, and blood pressure medications carry significant weight gain as a documented effect. If your weight shifted after a medication change, that connection belongs in the conversation with your doctor.

A thorough assessment looks at all of these. An appointment that ends with “eat less, move more” has looked at none of them.

Part 2: This Is Not About Who You Are

The Harm That Happens When Medicine Gets This Wrong

I want to say something that I don’t think gets said enough in clinical settings.

The stigma around weight is one of the most persistent forms of medical bias that exists, and it causes real, measurable harm. Patients with obesity receive fewer diagnostic workups. They spend less time with their physicians. They report feeling judged and dismissed. And they are significantly less likely to seek medical care as a result of it [1]. That last point is the one that quietly costs lives.

When your symptoms get attributed to your weight without investigation, you don’t receive the investigation. The thyroid that needs treatment doesn’t get treated. The hormonal shift that explains the last three years doesn’t get identified. The insulin resistance that has been building for a decade doesn’t get caught. Instead, you get sent home, sometimes with a pamphlet, sometimes with just a number goal and a referral to a nutritionist…and sometimes with nothing at all.

A 2025 Lancet commission, a landmark document from an international group of over 75 expert clinicians , drew a distinction I think every patient deserves to understand. There is a meaningful difference between having a higher body weight and having clinical obesity, which is defined as functional impairment and organ-specific complications that result from excess adiposity [1]. BMI does not reliably tell you which one you’re dealing with. Two people with the same BMI can have completely different metabolic profiles, completely different risks, and completely different clinical needs.

At Heal Integrative Wellness, I never make a clinical decision based on BMI alone. I look at body composition, metabolic markers, inflammatory status, hormonal profile and critically, how you actually feel. The number on the scale is one data point. It is not a diagnosis.

The rest of this masterclass — including what a complete metabolic workup for weight actually looks like, the dietary approaches with the most evidence behind them and why they work differently for different people, the honest conversation about GLP-1 medications, and the monitoring framework that tracks what actually matters — is available to paid subscribers.

Every piece in this series is written by our clinical team, grounded in peer-reviewed evidence, and built around the questions we hear most often from patients who deserve a fuller answer than they’ve been given.

Book A Consultation

Part 3: What Good Testing Actually Looks Like

What We Actually Look For

The 2025 Lancet commission on clinical obesity explicitly states that measures of central adiposity (not BMI alone) should guide clinical assessment and decision-making [1]. This reflects what clinicians who work in this space have known for a long time: where fat is stored matters as much as how much there is. Visceral fat — the fat that accumulates around abdominal organs — is metabolically active and inflammatory in a way that fat under the skin is not. Same BMI, very different biology.

A thorough assessment should include:

Waist circumference — the most practical proxy for visceral fat. Risk thresholds are generally greater than 94 cm (37 inches) for men and greater than 80 cm (31.5 inches) for women, with adjustments for different ethnic backgrounds [1]. Waist-to-hip ratio adds further context.

Body composition analysis — bioelectrical impedance or DEXA scanning to distinguish fat mass from lean mass. Two people at the same weight can look entirely different on a body composition scan — and the clinical picture is different in each case.

Fasting glucose, fasting insulin, and HOMA-IR — to assess insulin resistance specifically, because it is one of the most common drivers of weight that won’t shift and one of the most actionable. It also determines which dietary interventions will and won’t work for a particular person.

Full thyroid panel — TSH, free T3, free T4, and thyroid antibodies. Not just TSH. The reasons are covered in the next masterclass, but briefly: TSH alone misses subclinical hypothyroidism and Hashimoto’s, both of which affect weight and both of which are treatable.

Hormonal panel — sex hormones (testosterone total and free, estradiol, progesterone, LH, FSH, SHBG) and cortisol. Hormonal changes are among the most common and most under recognized contributors to weight that shifts without explanation.

Full metabolic panel including liver enzymes — as covered in the MASLD masterclass. Liver health and metabolic health are deeply intertwined. If enzymes are elevated, it belongs in the conversation.

CRP and inflammatory markers — elevated high-sensitivity CRP tells me the fat tissue is metabolically active and driving systemic inflammation. That’s a different clinical picture than the same weight without inflammation, and it changes what I prioritize.

Complete lipid panel with triglycerides — specifically looking for the pattern of high triglycerides, low HDL, and small dense LDL particles that accompanies insulin resistance and visceral fat. Standard LDL alone doesn’t tell this story.

Part 4: What Actually Moves the Needle

There Is No Single Answer… and That’s the Point!

There is no one dietary pattern that works for everyone. And this is not a diplomatic hedge — it reflects genuine biological differences between people. What works for someone whose weight is primarily driven by hyperinsulinemia looks different from what works for someone in perimenopause, which looks different again from someone whose weight shifted after years of poor sleep and elevated cortisol.

That said, here’s what the evidence actually supports:

Dietary quality matters more than any single macronutrient target. Mediterranean-style eating, DASH, and whole-food patterns consistently outperform macronutrient-defined diets in long-term outcomes [2, 3]. The common thread is food quality: minimally processed, nutrient-dense, not chronically spiking insulin, supporting the gut microbiome, and providing enough protein to protect lean mass.

For insulin-resistant patterns specifically, reducing refined carbohydrates is the most mechanistically logical step. This doesn’t mean zero carbohydrates, it means that whole food carbohydrates (legumes, vegetables, intact grains) metabolize differently from refined starches and added sugars, and the distinction matters more for insulin-resistant individuals than for anyone else.

Protein adequacy is not optional. During weight loss especially, adequate protein (generally 1.2–1.6g per kg of body weight) preserves lean mass, supports satiety, and maintains metabolic rate. Undereating protein while reducing calories is one of the most common and consequential errors I see.

Meal timing may matter as much as content. Glucose tolerance is highest earlier in the day. Time-restricted eating aligned with earlier hours (finishing eating earlier in the day and maintaining a meaningful overnight fast) has emerging evidence for metabolic benefit beyond calorie counting. The mechanisms involve circadian rhythm and insulin normalization.

Resistance training is the non-negotiable. Aerobic exercise is valuable. But preserving and building lean muscle mass is the single most important factor in preventing metabolic rate decline during weight loss. It also improves insulin sensitivity, supports bone density, and improves hormonal profiles in both sexes. I tell patients: cardiovascular exercise is medicine. Resistance training is essential medicine.

Sleep is not a lifestyle recommendation to slot in if you have time, it is a metabolic intervention. Insufficient sleep (under 7 hours for most adults) produces documented hormonal disruption that works directly against every other intervention in this list. If sleep isn’t addressed, everything else is working against a significant headwind.

Managing stress is not self-care in the abstract, it is clinical work. Chronic cortisol elevation drives visceral fat accumulation specifically, impairs insulin sensitivity, increases appetite and food cravings, and disrupts sleep. Meditation, breathwork, protecting rest, reducing overcommitment, these are not soft additions to a protocol. They address a documented hormonal driver of disease.

The Honest Conversation About GLP-1 Medications

This is the topic the last five years have transformed, and I want to address it with the nuance it deserves.

GLP-1 receptor agonists, semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are not diet pills. They act on receptors in the brain, gut, and pancreas to reduce appetite, slow gastric emptying, improve insulin secretion, and produce metabolic changes that lead to substantial, sustained weight loss in ways that weren’t previously achievable with medication [2].

The evidence is significant. Average weight loss with semaglutide 2.4 mg weekly is approximately 15% of body weight over 68 weeks, with meaningful improvements in blood pressure, triglycerides, blood sugar, liver fat, and inflammatory markers accompanying that loss [2]. Tirzepatide, targeting both GLP-1 and GIP receptors, produces even greater average weight loss in trials.

But I want to be clear about two things these medications are not:

They are not a permanent solution when used in isolation. In most patients, weight returns substantially when the medication is stopped — which means the underlying biology hasn’t changed, only been managed. My approach, and the one reflected in the 2025 Canadian guidelines, is that pharmacotherapy works best as part of a comprehensive program that identifies the drivers, builds genuine lifestyle infrastructure, and supports long-term metabolic health — not just short-term weight loss [2].

And they are not appropriate for everyone. GLP-1 medications are contraindicated in people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. They have a real side effect profile — primarily nausea and gastrointestinal symptoms — that requires careful dose escalation. And muscle loss during rapid weight loss is a genuine concern, which is exactly why protein adequacy and resistance training are not optional additions when someone is on a GLP-1.

At Heal Integrative Wellness, medication when indicated is part of a clinical protocol… not a prescription handed over with a three-month follow-up. The goal is a metabolic environment that supports health, with or without pharmacotherapy as part of the picture.

Part 5: Retesting and What to Watch

The 90-Day and 6-Month Check-In

At 90 days, I want the full metabolic panel — fasting glucose, insulin, HOMA-IR, triglycerides, HDL. Are the metabolic markers moving? Body weight matters less at this stage than metabolic direction. Someone who has lost 4% of body weight but whose fasting insulin has dropped substantially is on the right track, even if the scale feels disappointing.

At 6 months, I want to repeat body composition if available, reassess inflammatory markers, check liver enzymes if they were elevated at baseline, and revisit the hormonal panel if a hormonal driver was identified. This is when the pattern becomes clear.

For anyone on a GLP-1 medication: protein intake needs active monitoring, lean mass needs checking, and gastrointestinal tolerance needs honest assessment. Heart rate should also be tracked — GLP-1 agents can mildly elevate resting heart rate in some patients [2].

Between labs, track energy levels, sleep quality, hunger patterns, exercise tolerance, and mood. Weight is one signal. It is not the only one — and on some weeks, not even the most relevant one.

Come back sooner if severe nausea or vomiting isn’t resolving with dose adjustment, if weight is dropping faster than 1–1.5% of body weight per week sustained, if you notice significant muscle weakness, or if any new symptoms appeared after a medication change.

A Note on the Long Game

Obesity is a chronic disease. Like hypertension, like diabetes, like any other chronic condition, it requires long-term tending, not a 12-week intervention and a goal weight that serves as a finish line.

The patients I see who thrive over time are the ones who stop treating their body as a problem to solve and start treating their metabolic health as something to care for continuously. Who build real habits, address the actual drivers, use medication when it genuinely helps, and define success by how they feel, what their labs show, and what they’re able to do — not by a number. That shift, when it happens, is one of the most meaningful things I get to witness in practice.

If you’ve recognized yourself in any of this and want to understand what’s actually driving your picture, that’s the conversation we start with.

Book a Consultation with Heal Integrative Wellness